Merck & Co Stock

Merck & Co Share Buybacks

The Share Buybacks of Merck & Co (MRK) as of Aug 13, 2026 is -5.08 B USD. In the previous year, Share Buybacks was -1.31 B USD — a change of 289.28% (lower).

Share Buybacks

-5.08 BUSD

YoY

289.28%

Last updated:

Share Buybacks of Merck & Co is 2026 -5.08 B USD. Share Buybacks of Merck & Co was 2025 -1.31 B USD. It decreases by 289.28% lower compared to the previous year.
Access this data via the Eulerpool API

Merck & Co Stock analysis

What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck & Co stock

Share Buybacks of Merck & Co is -5.08 B USD in 2026.

Share Buybacks of Merck & Co changed from -1.31 B USD to -5.08 B USD, representing a 289.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Share Buybacks Merck & Co since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Merck & Co historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Merck & Co

All Key Metrics — Merck & Co